Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice

Ann N Y Acad Sci. 2000;920:328-31. doi: 10.1111/j.1749-6632.2000.tb06943.x.
No abstract available

MeSH terms

  • Administration, Intranasal
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / administration & dosage
  • Amyloid beta-Peptides / immunology*
  • Amyloid beta-Peptides / therapeutic use*
  • Amyloid beta-Protein Precursor / genetics*
  • Animals
  • Antibody Formation
  • Brain / pathology
  • Humans
  • Mice
  • Mice, Transgenic
  • Plaque, Amyloid / pathology

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor